主页 /
MDR-1339

MDR-1339

Name: MDR-1339
SKU: A21138

目录号: A21138

Aβ-aggregation inhibitor

MDR-1339 Chemical Structure

CAS NO. 1018946-38-7

MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor, used in the research of Alzheimer's disease.

库存：现货

规格	价格	数量
5 mg	￥ 1,490.00
10 mg	￥ 2,560.00
50 mg	￥ 7,590.00
100 mg	￥ 15,180.00

大包装询价

或

添加到收藏

产品仅用于科学研究，不针对患者销售，望谅解.

产品详情

生物活性

MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor, used in the research of Alzheimer's disease.

制备储备液

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.1 mM	30.64 mL	153.19 mL	306.38 mL
0.5 mM	6.13 mL	30.64 mL	61.28 mL
1 mM	3.06 mL	15.32 mL	30.64 mL
5 mM	0.61 mL	3.06 mL	6.13 mL

*The above data is based on the productmolecular weight 326.39. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

化学数据

目录号	A21138
作用机制	Inhibitor (抑制剂)
M. Wt	326.39
Formula	C20H22O4
Purity	>99%
Storage	Store lyophilized at -20ºC, keep desiccated. In lyophilized form, the chemical is stable for 36 months. In solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.
CAS No.	1018946-38-7
Synonyms	MDR 1339, MDR1339, DWK-1339, DWK1339, DWK 1339
SMILES	COCCCC1=CC=C(OC(C2=CC=C(OC)C(OC)=C2)=C3)C3=C1